New development in Valley fever vaccine for companion animalsOctober 15, 2018A novel Valley fever sub-unit vaccine for companion animals has been found by Mazen Animal Health to reduce the burden of coccidioides—the fungus that can cause Valley fever—in mice.
SPONSORED CONTENTSee what precise nutrition can do.Get to the bottom of tough gastrointestinal cases and recommend diets precisely designed to meet your patients' unique needs. + Find out more
Bayer, NeuroCycle partner to advance pet allergy treatmentsSeptember 18, 2018Bayer Animal Health and NeuroCycle Therapeutics Inc. have signed a global license agreement to advance allergy treatment options for companion animals. As part of the license agreement, Bayer will develop and commercialize novel compounds based on NeuroCycle's intellectual property. "[This] agreement underlines our strategy to combine the know-how from creative startup companies like NeuroCycle with opportunities derived from Bayer's research," said Douglas Hutchens, DVM, PhD, Bayer Animal Health's head of drug discovery, external innovation and chief veterinary officer. "It is a major milestone on our way to complementing our portfolio with novel treatment options against allergic diseases for the companion animal sector." The companies' goal is to maximize the humanitarian impact of their innovative technologies, according to Jed Hubbs, PhD, MS, CEO of NeuroCycle Therapeutics.
How bioinformatics research could affect veterinary practices, companion animal healthAugust 30, 2017Let’s face it; we can’t even keep up with all the email, client communications, and news flashing on our smartphones while maintaining a busy clinical load. Once-a-year continuing education barely keeps us afloat in the ocean of veterinary information, and now that information is coming at us more and more rapidly and in more forms.
